News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Release: Arzerra® Second Quarter 2013 Net Sales Figures


7/24/2013 9:25:03 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; July 24, 2013 – Genmab A/S (OMX: GEN) announced today that the Arzerra (ofatumumab) net sales during the second quarter of 2013 were GBP 17.8 million (approximately DKK 156 million). This figure consists of net sales in the U.S. of GBP 10.6 million and in the rest of the world of GBP 7.2 million. Under the terms of the collaboration with GlaxoSmithKline (GSK), Genmab expects to receive a royalty payment of approximately DKK 31 million.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES